Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(9 sites)
United States
The University of Texas Md Anderson Cancer Center, Houston, Texas Next Oncology, San Antonio, Texas Next Virginia, Fairfax, Virginia Australia
Blacktown Cancer and Haematology Centre, Blacktown, New South Wales Monash Health, Clayton, Victoria The Alfred Hospital, Melbourne, Victoria China
The First Affiliated Hospital of Xiamen University, Xiamen, Fujian Rui Jin Hospital Shanghai Jiao Tong University School of Medicinejiading Branch, Shanghai, Shanghai Municipality Zhejiang Cancer Hospital, Hangzhou, Zhejiang